The best word to describe this week in the contest is “mixed”. The market generally was flat, although the S&P biotech index had a decent (+1.3%) week. It still has a long way to go to catch up with the broader market NASDAQ composite for the year (up +5% vs +27%).
Looking at individual portfolio stocks for the week, both the best and the worst were strong YTD performers. First place CRVS added another +45% of their starting price building on last week’s second place return of +71%. On the other hand, INZY gave back (-31%) much of last week's gain (+49%). This didn’t change their YTD performance ranks, INZY still number 1 and CRVS number 2, their separation is smaller. Smaller wins and losses allowed OMER to pass JSPR for 3rd place.
The portfolios as whole showed some modest improvement, up about $1000 in both the average and median, but there was a wide dispersion in their performance, with 6 portfolios in the red for the week, and range of returns for the week was from RKRW (+$8k) to this week’s cellar dweller, who trimmed -$3.5k from their portfolio value. For the YTD portfolio rankings: a good week for first place ALONER, thanks to holding CRVS; vs. second BLADERUNNER’s loss primarily driven by JSPR’s decline for the week, adding another $4k to the gap between them. Big winner for the week RKRW, improved his RTD standing from 4th to 3rd.
Let’s see what the next week will bring.
Report Time Ranges
|
|
|
|
|
|
From
|
To
|
|
|
|
|
|
|
|
|
Recent
|
6/2/23
|
6/9/23
|
|
|
|
|
|
|
|
|
YTD
|
12/31/2022
|
|
|
|
|
Index Portfolios’ Performance
|
|
|
|
|
Symbol
|
Recent P/L
|
Recent %
|
YTD P/L
|
|
|
|
|
|
|
|
|
^IXIC
|
$175.59
|
0.1%
|
$26,681.97
|
|
|
|
|
|
|
|
|
^NBI
|
-$210.09
|
-0.2%
|
-$1,607.82
|
|
|
|
|
|
|
|
|
^SPSIBI
|
$1,352.73
|
1.3%
|
$5,123.99
|
|
|
|
|
Share Performance
|
Recent Performance
|
YTD Performance
|
|
Top Five
|
|
Bottom Five
|
|
Top Five
|
|
Bottom 5
|
Symbol
|
P/L / Initial Price
|
Symbol
|
P/L / Initial Price
|
Symbol
|
YTD P/L / Initial Price
|
Symbol
|
YTD P/L/ Initial Price
|
CRVS
|
44.7%
|
INZY
|
-31.4%
|
INZY
|
481.0%
|
APTA.L
|
-81.6%
|
HUMA
|
35.1%
|
PDSB
|
-26.7%
|
CRVS
|
321.2%
|
ALT
|
-75.7%
|
NAUT
|
29.4%
|
PTE
|
-24.1%
|
OMER
|
231.9%
|
PTE
|
-63.0%
|
ALVR
|
26.1%
|
LYEL
|
-20.7%
|
JSPR
|
225.1%
|
TCON
|
-60.3%
|
MOR
|
24.6%
|
GMDA
|
-15.5%
|
OCUL
|
164.4%
|
FULC
|
-57.6%
|
Average and Median Portfolio Performance
|
|
Recent P/L
|
|
|
|
YTD P/L
|
|
|
|
Avg.
|
Median
|
|
|
|
Avg
|
Median
|
|
|
|
$950.60
|
$957.10
|
BULBAMAN
|
|
$17,775.86
|
$15,259.59
|
TECHNETIUM
|
Top Seven Portfolio Performances
|
Top Recent Performers
|
Top YTD Performers
|
Contestant (Prev. Rank)
|
Recent P/L
|
P/L vs. ^SPSIBI
|
YTD P/L (Rank)
|
Contestant (Prev. Rank)
|
YTD P/L
|
vs. Top Portfolio
|
P/L vs. ^SPSIBI
|
Rec. P/L (Rank)
|
1 - RKRW (10)
|
$7,998.51
|
$6,645.79
|
$34,184.93 (3)
|
1 - ALONER (1)
|
$76,059.98
|
——
|
$70,935.99
|
$2,178.80 (5)
|
2 - RAJU_BIJLEE (15)
|
$5,171.03
|
$3,818.31
|
-$2,934.64 (12)
|
2 - BLADERUNNER (2)
|
$66,678.77
|
$9,381.21
|
$61,554.78
|
-$1,954.66 (12)
|
3 - STEVE LOKNESS (5)
|
$3,271.43
|
$1,918.70
|
$21,565.26 (5)
|
3 - RKRW (4)
|
$34,184.93
|
$41,875.05
|
$29,060.94
|
$7,998.51 (1)
|
4 - TECHNETIUM (12)
|
$2,760.78
|
$1,408.05
|
$15,259.59 (8)
|
4 - ERIKOTTO (3)
|
$30,242.38
|
$45,817.60
|
$25,118.39
|
$917.45 (9)
|
5 - ALONER (1)
|
$2,178.80
|
$826.07
|
$76,059.98 (1)
|
5 - STEVE LOKNESS (6)
|
$21,565.26
|
$54,494.71
|
$16,441.27
|
$3,271.43 (3)
|
6 - BMAZ001 (13)
|
$2,153.39
|
$800.66
|
-$25,818.88 (15)
|
6 - TOMATO (7)
|
$18,469.29
|
$57,590.69
|
$13,345.30
|
$1,897.77 (7)
|
7 - TOMATO (11)
|
$1,897.77
|
$545.04
|
$18,469.29 (6)
|
7 - ARTHUR RADLEY (5)
|
$17,804.99
|
$58,254.99
|
$12,681.00
|
-$2,538.76 (13)
|
Top Portfolios’ Contents
|
Top Recent Performance Portfolio (RKRW)
|
Top YTD Performance Portfolio (ALONER)
|
Symbol (Rank)
|
Current Allocation
|
Value/Total | ROI
|
YTD Stock P/L
|
Recent Stock P/L
|
% Current Price Change for $1,000 P/L
|
Symbol (Rank)
|
Initial Allocation
|
Value/Total | ROI
|
YTD Stock P/L
|
Recent Stock P/L
|
% Current Price Change for $1,000 P/L
|
ETON
|
10.0%
|
10.2% | 37.2%
|
$3,723.40
|
-$35.46
|
7.3%
|
AFMD
|
10%
|
4.4% | -38.2%
|
-$4,830.09
|
-$1,843.20
|
12.8%
|
HROW
|
10.0%
|
10.2% | 37.3%
|
$3,726.29
|
$474.25
|
7.3%
|
CDTX
|
10%
|
10.8% | 50.9%
|
$6,428.52
|
-$1,574.92
|
5.2%
|
KALV
|
10.0%
|
10.9% | 46.6%
|
$4,659.76
|
-$133.14
|
6.8%
|
CLSD
|
10%
|
8.4% | 16.6%
|
$2,098.45
|
$1,495.65
|
6.8%
|
KPTI
|
10.0%
|
4.8% | -35.0%
|
-$3,500.00
|
-$147.06
|
15.4%
|
CRDF
|
10%
|
8.2% | 14.0%
|
$1,762.87
|
-$88.83
|
6.9%
|
MOR
|
10.0%
|
15.5% | 108.4%
|
$10,837.99
|
$2,458.10
|
4.8%
|
CRIS
|
10%
|
9.7% | 34.8%
|
$4,391.60
|
-$1,456.12
|
5.9%
|
OCUL
|
10.0%
|
19.7% | 164.4%
|
$16,441.28
|
$1,814.95
|
3.8%
|
CRVS
|
10%
|
28.6% | 298.9%
|
$37,742.45
|
$5,346.58
|
2.0%
|
PHAT
|
10.0%
|
8.6% | 15.8%
|
$1,577.54
|
$1,185.38
|
8.6%
|
KZIA
|
10%
|
13.2% | 84.4%
|
$10,661.81
|
$1,273.66
|
4.3%
|
TCON
|
10.0%
|
3.0% | -60.3%
|
-$6,032.89
|
-$180.54
|
25.2%
|
MGTA
|
10%
|
11.4% | 58.8%
|
$7,427.86
|
-$423.92
|
5.0%
|
TELA
|
10.0%
|
7.2% | -3.8%
|
-$382.61
|
$408.70
|
10.4%
|
MRNA
|
10%
|
5.3% | -25.9%
|
-$3,275.33
|
-$550.11
|
10.7%
|
URGN
|
10.0%
|
9.8% | 31.3%
|
$3,134.16
|
$2,153.33
|
7.6%
|
PRVB
|
10%
|
0.0% | 136.5%
|
$13,651.84
|
$0.00
|
|
|
